Brief: Consun Pharmaceutical Group FY Profit Attributable RMB396.2 Mln
March 21 (Reuters) - Consun Pharmaceutical Group Ltd
1681.HK :
* PROFIT FOR YEAR ENDED 31 DECEMBER 2017 ATTRIBUTABLE
RMB396.2
MILLION, AN INCREASE OF 28.8%
* PROPOSED TO DECLARE A FINAL DIVIDEND OF HKD0.10 PER
SHARE
* FY REVENUE RMB1.66 BILLION VERSUS RMB1.22 BILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKSbR5clZ
Further company coverage: 1681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director